HYDROMORPHONE HCL ER 12 MG TAB

What it is

HYDROMORPHONE HCL ER 12 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as hydromorphone hydrochloride.

FDA gives its dosage form as tablet, extended release and its route as oral.

Its labelers, the companies named on the label, are Padagis US LLC, Trigen Laboratories, LLC and Camber Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Opioid Agonist.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $312.64 for 30 tablets (30 × $10.42125 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 tablets · NADAC explanation codes

All 3 NDCs

• 00574-0294-01 · Padagis US LLC · $10.42125 per EA · eff. 2026-09-23 filed
• 13811-0702-10 · Trigen Laboratories, LLC · $10.42125 per EA · eff. 2026-09-23 filed
• 31722-0120-01 · Camber Pharmaceuticals, Inc. · $10.42125 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

12 other products in the NADAC file share the FDA nonproprietary name hydromorphone hydrochloride with HYDROMORPHONE HCL ER 12 MG TAB.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-07-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $10.42125 per EA filed.

Of the 108 other products in FDA’s Opioid Agonist class priced per EA, 25 have a higher middle NADAC price and 83 a lower one. The one in the middle is BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP, at $0.79784 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $240.75 for 30 tablets, at an average of $8.02501 per EA in 2024 (2024-01-01 to 2024-12-31) for “Hydromorphone ER” and “Hydromorphone HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 14,879 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.